Log on / register
Feedback | Support | My details
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.
Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C
Genome Biol 2007, 8:R157
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
36%36%


 Research article    
Intrinsic bias in breast cancer gene expression data sets
Mosley JD, Keri RA
BMC Cancer 2009, 9:214 (29 June 2009)
 [Abstract] [Provisional PDF] [PubMed] [Related articles]
2.
36%36%


 Research article    
Effects of sample size on robustness and prediction accuracy of a prognostic gene signature
Kim SY
BMC Bioinformatics 2009, 10:147 (16 May 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
3.
36%36%


 Research article    
Comparative expression pathway analysis of human and canine mammary tumors
Uva P, Aurisicchio L, Watters J, Loboda A, Kulkarni A, Castle J, Palombo F, Viti V, Mesiti G, Zappulli V, Marconato L, Abramo F, Ciliberto G, Lahm A, La Monica N, de Rinaldis E
BMC Genomics 2009, 10:135 (27 March 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
4.
36%36%


 Research article    
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, Solbach C, Hanker L, Ahr A, Metzler D, Engels K, Karn T, Kaufmann M
Breast Cancer Research 2009, 11:R15 (9 March 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
5.
36%36%


 Research article    
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer
Reyal F, van Vliet MH, Armstrong NJ, Horlings HM, de Visser KE, Kok M, Teschendorff AE, Mook S, van 't Veer L, Caldas C, Salmon RJ, Vijver MJ, Wessels LFA
Breast Cancer Research 2008, 10:R93 (13 November 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
6.
36%36%


 Research article    
A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer
Teschendorff AE, Caldas C
Breast Cancer Research 2008, 10:R73 (28 August 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
7.
36%36%


 Research article    
Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability
van Vliet MH, Reyal F, Horlings HM, van de Vijver MJ, Reinders MJT, Wessels LFA
BMC Genomics 2008, 9:375 (6 August 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
8.
36%36%


 Research article    
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M
Breast Cancer Research 2008, 10:R65 (28 July 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
9.
36%36%


 Research    
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, Thorne NP, Costa JL, Pinder SE, van de Wiel MA, Green AR, Ellis IO, Porter PL, Tavaré S, Brenton JD, Ylstra B, Caldas C
Genome Biology 2007, 8:R215 (7 October 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 2 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.